Literature DB >> 30909213

Using Varying Diagnostic Criteria to Examine Mild Cognitive Impairment Prevalence and Predict Dementia Incidence in a Community-Based Sample.

Kayela Robertson1, Eric B Larson2, Paul K Crane3, Brenna Cholerton4, Suzanne Craft5, Wayne C McCormick3, Susan M McCurry6, James D Bowen7, Laura D Baker5, Emily H Trittschuh1,8.   

Abstract

Lack of a unitary operational definition of mild cognitive impairment (MCI) has resulted in mixed prevalence rates and unclear predictive validity regarding conversion to dementia and likelihood of reversion. We examined 1,721 nondemented participants aged 65 and older from the Adult Changes in Thought (ACT) community-based cohort. Participants were followed longitudinally through biennial visits (average years assessed = 5.38). Categorization of MCI was based on: 1) deviation of neuropsychological test scores from a benchmark based on either standard or individualized expectations of a participant's mean premorbid cognitive ability, and 2) cutoff for impairment (1.0 versus 1.5 standard deviations [sd] below benchmark). MCI prevalence ranged from 56-92%; using individualized benchmarks and less stringent cutoffs produced higher rates. During follow-up, 17% of the cohort developed dementia. Examination of sensitivity, specificity, and predictive validity revealed that the criterion of 1.5 sd from the standardized benchmark was optimal, but still had limited predictive validity. Participants meeting this criterion at their first visit were three times more likely to develop dementia and this increased to seven times if participants had this diagnosis at the second timepoint as well. Those who did not have an MCI diagnosis at their first visit, but did at their second, had a significant increase of risk (but to a lesser extent than those diagnosed at both visits), while those who had an MCI diagnosis at their first visit, but not their second, did not have a significantly increased risk. These results highlight how assessing MCI stability greatly improves prediction of risk.

Entities:  

Keywords:  Cognitive dysfunction; dementia; epidemiology; incidence; prevalence

Year:  2019        PMID: 30909213     DOI: 10.3233/JAD-180746

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.

Authors:  Kathryn N Devlin; Laura Brennan; Laura Saad; Tania Giovannetti; Roy H Hamilton; David A Wolk; Sharon X Xie; Dawn Mechanic-Hamilton
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

2.  Observational study of patient characteristics associated with a timely diagnosis of dementia and mild cognitive impairment without dementia.

Authors:  Lindsay White; Bailey Ingraham; Eric Larson; Paul Fishman; Sungchul Park; Norma B Coe
Journal:  J Gen Intern Med       Date:  2021-10-13       Impact factor: 6.473

3.  Diagnostic accuracy of cognitive screening tools under different neuropsychological definitions for poststroke cognitive impairment.

Authors:  Xiangliang Chen; Yunfei Han; Junshan Zhou; Minmin Ma; Xinfeng Liu
Journal:  Brain Behav       Date:  2020-07-03       Impact factor: 2.708

4.  The complex burden of determining prevalence rates of mild cognitive impairment: A systematic review.

Authors:  Maria Casagrande; Giulia Marselli; Francesca Agostini; Giuseppe Forte; Francesca Favieri; Angela Guarino
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.